Cargando…
Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
BACKGROUND: Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed serum-immunoprecipitations with patient antibodies followed by mass spectrometry (LC-MS/MS) to obtain an unbiased view of all possible autoantibody targets and their a...
Autores principales: | Johnson, Michael E., Grassetti, Andrew V., Taroni, Jaclyn N., Lyons, Shawn M., Schweppe, Devin, Gordon, Jessica K., Spiera, Robert F., Lafyatis, Robert, Anderson, Paul J., Gerber, Scott A., Whitfield, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724133/ https://www.ncbi.nlm.nih.gov/pubmed/26801089 http://dx.doi.org/10.1186/s13075-016-0914-4 |
Ejemplares similares
-
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies
por: Gordon, Jessica, et al.
Publicado: (2011) -
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
por: Spiera, Robert, et al.
Publicado: (2020) -
High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis
por: Arron, Sarah T., et al.
Publicado: (2014) -
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
por: Gordon, Jessica K., et al.
Publicado: (2015) -
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
por: Taroni, Jaclyn N., et al.
Publicado: (2017)